Novel Conformation-Dependent Tau Antibodies Are Modulated by Adjacent Phosphorylation Sites

• Published in: International journal of molecular sciences Vol. 24; no. 18; p. 13676
• Main Authors: Paterno, Giavanna, Torrellas, Jose, Bell, Brach M, Gorion, Kimberly-Marie M, Quintin, Stephan S, Hery, Gabriela P, Prokop, Stefan, Giasson, Benoit I
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.09.2023; MDPI
• Subjects: Advertising executives; Alzheimer's disease; Amino acids; Antibodies; Antigenic determinants; Brain; conformation; Ethylenediaminetetraacetic acid; Immunization; Kinases; Monoclonal antibodies; Mutation; Nervous system diseases; Neuropathology; pathological; Peptides; Phosphorylation; Proteins; Scientific equipment and supplies industry; tau; United States; Massachusetts
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms241813676

Tau proteins within the adult central nervous system (CNS) are found to be abnormally aggregated into heterogeneous filaments in neurodegenerative diseases, termed tauopathies. These tau inclusions are pathological hallmarks of Alzheimer’s disease (AD), Pick’s disease (PiD), corticobasal degeneration (CBD), and progressive supranuclear palsy (PSP). The neuropathological hallmarks of these diseases burden several cell types within the CNS, and have also been shown to be abundantly phosphorylated. The mechanism(s) by which tau aggregates in the CNS is not fully known, but it is hypothesized that hyperphosphorylated tau may precede and further promote filament formation, leading to the production of these pathological inclusions. In the studies herein, we generated and thoroughly characterized two novel conformation-dependent tau monoclonal antibodies that bind to residues Pro218-Glu222, but are sensitive to denaturing conditions and highly modulated by adjacent downstream phosphorylation sites. These epitopes are present in the neuropathological hallmarks of several tauopathies, including AD, PiD, CBD, and PSP. These novel antibodies will further enable investigation of tau-dependent pathological inclusion formation and enhance our understanding of the phosphorylation signatures within tauopathies with the possibility of new biomarker developments.